Log In
Print
BCIQ
Print
Print this Print this
 

Omidria (OMS302)

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionCombination of ketorolac, an anti-inflammatory agent, and phenylephrine, a pupil dilating agent
Molecular Target Cyclooxygenases (COX) ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationCataract
Indication DetailsMaintain pupil dilation during cataract and other lens replacement surgery and reduce post-operative pain and irritation; Maintain pupil dilation during cataract and other lens replacement surgery and reduce post-operative pain and irritation in pediatric patients
Regulatory Designation

U.S. - Standard Review (Maintain pupil dilation during cataract and other lens replacement surgery and reduce post-operative pain and irritation);
EU - Standard Review (Maintain pupil dilation during cataract and other lens replacement surgery and reduce post-operative pain and irritation)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today